Lung Biopsy Technology at Wellstar Reduces Complications, Speeds Up Treatment

Wellstar’s Comprehensive Aortic Program has identified thousands of hidden aneurysms in the past two years. The goal of the program is to help people before their conditions become life-threatening.

Aortic aneurysms are bulges in the body’s largest blood vessel. They can burst and cause severe damage or death if they become too big. Unfortunately, most people never know they have one because they are typically asymptomatic until they rupture.

However, the aortic experts at Wellstar found a way to help people before they have an emergency.

“When patients have CT scans at Wellstar for other reasons, we use artificial intelligence (AI) to sift through them and find images of someone who may have aneurysm,” said Wellstar Cardiothoracic Surgeon Dr. James Ryan Burke. “That allows us to proactively contact them and bring them in if appropriate for evaluation to discuss that diagnosis.”

Since the program launch in July 2022, more than 4,700 people with aneurysms have been placed under surveillance—a protocol to monitor people who have a risk. Surveillance allows people to avoid undergoing unnecessary surgery but to know when the aneurysm grows larger and becomes a greater concern.

For people who had large, potentially life-threatening aneurysms, cardiovascular surgeons and vascular surgeons performed more than 700 advanced procedures at Wellstar Kennestone Regional Medical Center since the program began.

“These are major cardiac operations only performed in centers that offer complex aortic surgery,” Dr. Burke said. “The outcomes are best when done in experienced centers that do a high volume of procedures, like Wellstar Kennestone.”

Patient-centered aortic care

“This program is very patient-oriented. We have an excellent team of dedicated physicians at Wellstar to accomplish our mission and I think it’s very beneficial for both patients and physicians,” said Dr. Michael Corey of Vascular Surgical Associates.

The aortic program at Wellstar provides a higher level of aortic care than a patient would typically find in a local hospital. What makes the program unique is:

• The multispecialty team of aortic experts working together
• The cutting-edge AI technology used to identify patients who are unaware they have an aneurysm
• A high-tech hybrid operating room (OR) for open or minimally invasive procedures
• The latest surgical techniques and technology
• A high volume of procedures performed

“The aorta is the largest blood vessel in the body. It runs from the heart, through the chest and abdomen and down to the legs,” said Dr. Burke. “When you have a disease process involving the aorta, it requires multiple specialties.”

Wellstar’s specialized aortic team includes cardiovascular surgeons, vascular surgeons, cardiologists, anesthesiologists, radiologists, nurse practitioners and physician assistants.

There is also a cardiac hybrid OR that brings a catheterization lab and surgery suite together in one space, making aortic aneurysm treatment more efficient and encouraging collaboration between our expert providers.

“The hybrid OR is a state-of-the-art, innovative, open operating room where patients can receive complex aortic reconstructions—procedures that have open surgery components to them—as well as endovascular (or minimally invasive) aortic reconstructions. This all can take place in one nice operating room,” Dr. Corey said.

The aortic program is part of a larger heart care program at Wellstar, based at Wellstar Kennestone, the first in Georgia and the fourth in the nation to receive Comprehensive Cardiac Care Center Certification by The Joint Commission and American Heart Association. This is the highest certification in cardiovascular care.

Learn more or schedule an appointment with an aortic disease specialist.

It seems "defeat" just isn't in John Cashen's vocabulary. A survivor in more ways than one, John has overcome not only a catastrophic natural disaster, but also fought cancer with unyielding resilience.

In 2005, as flood waters from Hurricane Katrina rose and threatened his New Orleans home, John took an axe to his attic's ceiling, climbed atop his roof and tied himself to his chimney so he wouldn't be swept away. Days later, no help had arrived, so John untied himself and swam to an overpass where he was rescued by a helicopter. He joined the rest of his family in Georgia.

Since then, John has become a proud citizen of LaGrange. A master of everything Mardi Gras, John runs a local krewe and is a natural at building parade floats from the foundation up. But when he was diagnosed with lung cancer in 2019, he summoned his fighting spirit, squared his shoulders, and faced his cancer journey head on.

The Wellstar Georgia Cancer Center Pharmacogenomics Program (CaPP) has launched pharmacogenomics testing services for the center’s patients and oncologists. Pharmacogenomics employs genetic sequence alterations in drug metabolism genes to predict toxicity.

The tests measure changes in genes that make proteins that metabolize common chemotherapy drugs. If a patient has a mutation in these genes, their metabolism will not handle the drug properly. This may cause the patient to become sick.

“These tests can help people avoid severe toxicity from chemotherapy. We want to optimize treatment for patients who need a lower dose when they have any gene mutation,” said Dr. John W. Henson, director of neuro-oncology at the Medical College of Georgia and the Wellstar Georgia Cancer Center. The Pharmacogenomics Program is co-led by Henson in the Hereditary Cancer Clinic and Dr. Katherine Saunders-Wohlfrom in Oncology Pharmacy.

The program’s initial focus will be on patients with gastrointestinal cancers in conjunction with Dr. Asha Nayak. Henson said this is where the biggest impact will come right away. Other service lines, including breast cancer, will benefit as more testing is done.

“This is a valuable message to the community,” said Henson. “CaPP services will include testing support, report interpretation, document management, clinician consultation, and patient and family consultation.”

Henson also thanked Dr. Brandy D. Gunsolus in Clinical Laboratory Science for her help with the program, saying she was instrumental in developing the order process.